Cynata Therapeutics Ltd - ESG Rating & Company Profile powered by AI
The ESG rating for Cynata Therapeutics Ltd indicates its reporting of the United Nations SDGs. The ESG score includes 17 UN SDGs including: 'Affordable & Clean Energy', 'Sustainable Cities & Communities' and 'Peace, Justice & Strong Institutions'. The webpage is a zero-cost Sustainability report covering Cynata Therapeutics Ltd.
Cynata Therapeutics Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.4; made up of an environmental score of 5.3, social score of 4.0 and governance score of 6.9.
5.4
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 835 | Wuhan Keqian Biology Co Ltd | 5.5 | High |
| 835 | dorsaVi Ltd | 5.5 | High |
| 886 | Cynata Therapeutics Ltd | 5.4 | High |
| 886 | Avant Brands Inc | 5.4 | High |
| 886 | Antengene Corporation Ltd | 5.4 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Cynata Therapeutics Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Cynata Therapeutics Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Cynata Therapeutics Ltd report the average age of the workforce?
Sign up for free to unlockDoes Cynata Therapeutics Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Cynata Therapeutics Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Cynata Therapeutics Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Cynata Therapeutics Ltd offer flexible work?
Sign up for free to unlockDoes Cynata Therapeutics Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Cynata Therapeutics Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Cynata Therapeutics Ltd conduct supply chain audits?
Sign up for free to unlockDoes Cynata Therapeutics Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Cynata Therapeutics Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Cynata Therapeutics Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Cynata Therapeutics Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Cynata Therapeutics Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Cynata Therapeutics Ltd disclose water use targets?
Sign up for free to unlockDoes Cynata Therapeutics Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Cynata Therapeutics Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Cynata Therapeutics Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Cynata Therapeutics Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Cynata Therapeutics Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Cynata Therapeutics Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Cynata Therapeutics Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Cynata Therapeutics Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Cynata Therapeutics Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Cynata Therapeutics Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Cynata Therapeutics Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Cynata Therapeutics Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Cynata Therapeutics Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Cynata Therapeutics Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Cynata Therapeutics Ltd disclose its waste policy?
Sign up for free to unlockDoes Cynata Therapeutics Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Cynata Therapeutics Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Cynata Therapeutics Ltd disclose energy use targets?
Sign up for free to unlockDoes Cynata Therapeutics Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Cynata Therapeutics Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Cynata Therapeutics Ltd
These potential risks are based on the size, segment and geographies of the company.
Cynata Therapeutics Limited, together with its subsidiaries, develops and commercializes a proprietary mesenchymal stem cell technology under the Cymerus brand for human therapeutic use in Australia. The company's lead therapeutic product candidate is CYP-001, which has completed Phase I clinical trial for the treatment of graft versus host disease. It also develops CYP-004, which is in Phase III clinical trial used for the treatment of osteoarthritis; and CYP-006TK, a novel polymercoated silicon wound dressing for diabetic wounds. In addition, the company develops products for the treatment of asthma, heart attack, coronary artery disease, acute respiratory distress syndrome, brain cancer, sepsis, critical limb ischemia, idiopathic pulmonary fibrosis, and renal transplantation. Cynata Therapeutics Limited has a strategic partnership with Fujifilm to provide clinical and commercial manufacturing services for, and supply of, Cynata's Cymerus therapeutic mesenchymal stem cell products. The company was formerly known as Eco Quest Limited and changed its name to Cynata Therapeutics Limited in October 2013. Cynata Therapeutics Limited was incorporated in 2003 and is based in Cremorne, Australia.